关注
Joshua Wald
Joshua Wald
Assistant Professor of Medicine, McMaster University
在 medportal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Telehealth pulmonary rehabilitation: a review of the literature and an example of a nationwide initiative to improve the accessibility of pulmonary rehabilitation
AM Selzler, J Wald, M Sedeno, T Jourdain, T Janaudis-Ferreira, ...
Chronic Respiratory Disease 15 (1), 41-47, 2018
1082018
GOLD stage and treatment in COPD: a 500 patient point prevalence study
KA Safka, J Wald, H Wang, L McIvor, A McIvor
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 4 (1), 45, 2017
482017
Delivering pulmonary rehabilitation during the COVID-19 pandemic: A Canadian Thoracic Society position statement
G Dechman, R Aceron, M Beauchamp, M Bhutani, J Bourbeau, D Brooks, ...
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 4 (4 …, 2020
422020
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
SA Guler, S Am Hur, MK Stickland, P Brun, L Bovet, AE Holland, ...
Thorax 77 (6), 589-595, 2022
312022
Validity of balance and mobility screening tests for assessing fall risk in COPD
R McLay, RN Kirkwood, A Kuspinar, J Richardson, J Wald, N Raghavan, ...
Chronic respiratory disease 17, 1479973120922538, 2020
312020
2023 Canadian Thoracic Society guideline on pharmacotherapy in patients with stable COPD
J Bourbeau, M Bhutani, P Hernandez, SD Aaron, MF Beauchesne, ...
Chest, 2023
302023
Physical function and frailty for predicting adverse outcomes in older primary care patients
S O’Hoski, JF Bean, J Ma, HY So, A Kuspinar, J Richardson, J Wald, ...
Archives of physical medicine and rehabilitation 101 (4), 592-598, 2020
302020
Prevalence and prognostic impact of physical frailty in interstitial lung disease: a prospective cohort study
MAM Farooqi, S O'Hoski, S Goodwin, N Makhdami, A Aziz, G Cox, J Wald, ...
Respirology 26 (7), 683-689, 2021
262021
Key highlights of the Canadian Thoracic Society’s position statement on the optimization of COPD management during the coronavirus disease 2019 pandemic
M Bhutani, P Hernandez, J Bourbeau, G Dechman, E Penz, R Aceron, ...
Chest 158 (3), 869-872, 2020
212020
Addressing therapeutic questions to help Canadian health care professionals optimize COPD management for their patients during the COVID-19 pandemic
M Bhutani, P Hernandez, J Bourbeau, G Dechman, E Penz, R Aceron, ...
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 4 (2), 77-80, 2020
172020
Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation
MK Beauchamp, T Janaudis-Ferreira, J Wald, R Aceron, M Bhutani, ...
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 6 (1), 9-13, 2022
132022
Triaging access to critical care resources in patients with chronic respiratory diseases in the event of a major COVID-19 surge: key highlights from the Canadian Thoracic …
S Gupta, J Batt, J Bourbeau, KR Chapman, A Gershon, J Granton, ...
Chest 158 (6), 2270-2274, 2020
122020
Evaluation of an enhanced pulmonary rehabilitation program: a randomized controlled trial
AM Selzler, T Jourdain, J Wald, M Sedeno, T Janaudis-Ferreira, ...
Annals of the American Thoracic Society 18 (10), 1650-1660, 2021
92021
Benralizumab for prednisone-dependent eosinophilic asthma associated with novel STAT3 loss of function mutation
A Adatia, CJ Allen, J Wald, CD Richards, S Waserman, P Nair
Chest 159 (4), e181-e184, 2021
82021
KEY HIGHLIGHTS of the Canadian Thoracic Society’s position statement on the optimization of chronic obstructive pulmonary disease management during the COVID-19 pandemic
M Bhutani, P Hernandez, J Bourbeau, G Dechman, E Penz, R Aceron
Chest 158 (3), 869-72, 2020
82020
Self-management in pulmonary rehabilitation
J Bourbeau, W Alsowayan, J Wald
Textbook of pulmonary rehabilitation, 217-232, 2018
82018
A tool to assess participation in people with COPD: Validation of the late life disability instrument
S O’Hoski, A Kuspinar, J Richardson, J Wald, D Brooks, R Goldstein, ...
Chest 159 (1), 138-146, 2021
62021
Content validity of preference-based measures for economic evaluation in chronic obstructive pulmonary disease
A Mehdipour, S O’Hoski, MK Beauchamp, J Wald, A Kuspinar
Health and Quality of Life Outcomes 19, 1-10, 2021
52021
Position statement from the Canadian Thoracic Society (CTS) on clinical triage thresholds in respiratory disease patients in the event of a major surge during the COVID-19 pandemic
S Gupta, J Batt, J Bourbeau, KR Chapman, A Gershon, J Granton, ...
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 4 (4 …, 2020
52020
Measurement properties of preference-based measures for economic evaluation in COPD: a systematic review
A Mehdipour, MK Beauchamp, J Wald, N Peters, A Kuspinar
Quality of Life Research 29, 2875-2885, 2020
52020
系统目前无法执行此操作,请稍后再试。
文章 1–20